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7Comparison of Routine Brain Imaging at 3 T and 7 T
Elisabeth Springer, MD,* Barbara Dyedmerska, MSc,* Pedro Lima Cardoso, MSc,*
Simon Daniel Robinson, PhD,* Christian Weisstanner, MD,† Roland Wiest, MD,†
Benjamin Schmitt, PhD,‡§ and Siegfried Trattnig, MD*k
Objective: The aim of this study was to compare quantitative and semiquantitative
Conclusions: Ultra–high-field magnetic resonance imaging at 7 T comparge
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h,parameters (signal-to-noise ratio [SNR], contrast-to-noise ratio [CNR], ima
quality, diagnostic confidence) from a standard brain magnetic resonance ima
ing examination encompassing common neurological disorders such as demyeli
ating disease, gliomas, cerebrovascular disease, and epilepsy, with comparab
sequence protocols and acquisition times at 3 T and at 7 T.
Materials and Methods: Ten healthy volunteers and 4 subgroups of 40 patien
in total underwent comparable magnetic resonance protocols with standa
diffusion-weighted imaging, 2D and 3D turbo spin echo, 2D and 3D gradie
echo and susceptibility-weighted imaging of the brain (10 sequences) at 3
and 7 T. The subgroups comprised patients with either lesional (n = 5)
nonlesional (n = 4) epilepsy, intracerebral tumors (n = 11), demyelinating disea
(n = 11) (relapsing-remitting multiple sclerosis [MS, n = 9], secondary progre
sive MS [n = 1], demyelinating disease not further specified [n = 1]), or chron
cerebrovascular disorders [n = 9]). For quantitative analysis, SNR and CNR we
determined. For a semiquantitative assessment of the diagnostic confidence,
10-point scale diagnostic confidence score (DCS) was applied. Two experienc
radiologists with additional qualification in neuroradiology independently a
sessed, blinded to the field strength, 3 pathology-specific imaging criteria in ea
of the 4 disease groups and rated their diagnostic confidence. The overall ima
quality was semiquantitatively assessed using a 4-point scale taking into accou
whether diagnostic decision making was hampered by artifacts or not.
Results:Without correction for spatial resolution, SNR was higher at 3 Texce
in the T2 SPACE 3D, DWI single shot, and DIR SPACE 3D sequences. The SN
corrected by the ratio of 3 T/7 T voxel sizes was higher at 7 T than at 3 T in 10
11 sequences (all except for T1 MP2RAGE 3D).
In CNR, there was a wide variation between sequences and patient c
horts, but average CNR values were broadly similar at 3 T and 7 T.
DCS values for all 4 pathologic entities were higher at 7 T than at 3
The DCS was significantly higher at 7 T for diagnosis and exclusion of cortic
lesions in vascular disease. A tendency to higher DCS at 7 T for cortical lesio
in MS was observed, and for the depiction of a central vein and iron depos
within MS lesions. Despite motion artifacts, DCS values were higher at 7
for the diagnosis and exclusion of hippocampal sclerosis in mesial temporal lo
epilepsy (improved detection of the hippocampal subunits). Interrater agreeme
was 69.7% at 3 T and 93.3% at 7 T. There was no significant difference
the overall image quality score between 3 T and 7 T taking into account wheth
diagnostic decision making was hampered by artifacts or not.in
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O perational whole-body human 7 Tultra–high-field magnetic resnance (MR) units are currently available in approximately 60 ce
ters worldwide. These are currently only used for ethically approve
clinical research because no Conformité Européenne labelling or oth
regulatory approval for clinical use is available for 7 TMR systems. B
cause signal-to-noise ratio (SNR) scales linearly with the static ma
netic field strength (B0), most applications at 7 T are driven by th
need to obtain higher spatial resolution and gray matter (GM)/whi
matter (WM) contrast.1 Ultra–high-field MR imaging (MRI) provid
additional morphologic, functional,2,3 metabolic,4 and biochemical5 i
formation about the brain.
New insights into cortical lesions (CLs) in cerebrovascular di
ease6 and in multiple sclerosis (MS)7 in vitro have been gained recentl
and an increasing number of clinically focussed in vivo studies
7 T are being conducted.8–10 Using susceptibility-weighted imagin
(SWI), the plaque-vessel relationship,11 iron deposits,12 and tempor
evolution13 in MS may be better evaluated with 7 T, as well as the m
crovasculature in gliomas.14 Imaging of the hippocampus, notably su
fields of the internal hippocampal anatomy, and the sometimes on
subtle alterations due to repetitive epileptic seizures, may benefit fro
improved spatial resolution.15 However, in vivo studies that compa
7 Twith 3 T are still rare.16–19
Magnetic resonance examinations at 3 T have become part of th
clinical routine since approximately the year 2000. These are now co
sidered as the relative criterion standard because these routine clinic
scanners are equipped with the most advanced hardware, in particula
a range of dedicated multichannel receive radiofrequency coils for di
ferent clinical questions.
In assessing the clinical value of moving to higher field strengt
the crucial point is whether or not ultra–high-field imaging of the bra
at 7 T is advantageous compared with high-field imaging at 3 Twhe
applying routine sequences, not only for just 1 or 2 pathological fin
ings, but for the most important pathological findings of common di
eases of the brain.
This study aims to compare quantitative and semiquantitative p
rameters (SNR, contrast-to-noise ratio [CNR], image quality, diagnost
confidence) of routine brain MRI examinations with comparable s
quences and similar scan time at 3 Tand 7 T, evaluating 3 important im
aging criteria within 4 common disease groups of the brain (vascul
disease, demyelinating disease, temporal lobe epilepsy (TLE), an
tumor disease).
MATERIALS AND METHODS
The local ethics committee approved this study. Written informe
consent was obtained from all subjects. The clinical investigation wwww.investigativeradiology.com 1
zed reproduction of this article is prohibited.                                                                   
 unique DOI number which can be found in the footnotes.
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              performed in full compliance with the valid legal regulations accordin
to the Medical Device Law (MPG Medizinproduktegesetz) of the R
public of Austria and ISO 14155.
A total of 10 volunteers (6 women and 4 men; median ag
27.5 years; range, 22–60 years) and 40 patients (20 women an
20 men; median age, 42.5 years; range, 19–92 years) underwent MR
with a protocol of 10 comparable sequences at 3 T and 7 T with th
same acquisition time, but some different parameter settings due to di
ferent field strengths. In addition, 10 volunteers (1 woman and 9 me
median age, 24.5 years; range, 19–37 years) underwent task-free bloo
oxygenation level-dependent functional MRI (fMRI).
With the exception of fMRI, a fully comprehensive set of routin
sequences for a standardMRI examination of the brain were performe
covering demyelinating disease, tumor disease, microvascular diseas
and epileptogenic disorders.
Patients were referred to our department during diagnost
workups for TLE (n = 9) (mesial temporal lobe epilepsy [n = 5], uncle
seizure focus [n = 4]), brain tumors (n = 11), demyelinating disea
(n = 11) (relapsing-remitting MS [n = 9], secondary progressive M
[n = 1], demyelinating disease not further specified [n = 1]), or f
suspicion of chronic vascular disease (n = 9).
All subjects were scanned on an investigational 7 Twhole-bod
MR scanner (Siemens Healthcare, Erlangen, Germany) equippedwith
32-channel head coil (Nova Medical, Wilmington, MA) and on a 3
MAGNETOM Trio, a Tim System (Siemens Healthcare, Erlange
Germany) equipped with a 32-channel Siemens head coil. The 3
and 7 T measurements were performed on the same day for 37 patien
and 19 volunteers, in 3 patients within 4 days, and in 1 volunteer wh
underwent fMRI without a task within 4 days. The following sequenc
were acquired (with parameters listed in Table 1):
1. Magnetization prepared rapid acquisition gradient echo sequen
with bias field correction (MP2RAGE)20
2. 2D turbo spin echo (T2 TSE 2D)
3. 2D FLAIR TSE (FLAIR TSE 2D)
4. 3D FLAIR TSE with variable flip angle (FLAIR SPACE 3D)
5. High-resolution axial 3D flow-compensated T2*-weighted grad
ent echo sequence (T2* GRE)
6. Single-shot diffusion-weighted echo planar imaging (EPI) (DW
single shot)
7. Multishot readout-segmented diffusion-weighted EPI with 2D na
igator correction (DWI RESOLVE)21
8. 2D gradient echo EPI (fMRI)
9. 3D T2-weighted TSE with variable flip angle (T2 SPACE 3D)
10. T1-weighted spoiled gradient echo sequence (T1 FLASH)
11. 3D double inversion recovery TSE with variable flip angle (DI
SPACE 3D)
In the TLE cohort, a coronal 2D T2 TSE sequence with 25 slic
was additionally acquired. At 3 T, this had a matrix size of 512  46
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r-(0.5  0.4  1.5 mm voxels), turbo factor of 15 with 31 echo train
per slice, echo time (TE)/repetition time (TR) = 110/5420 millisecond
flip angle (FA) = 180 degrees, bandwidth = 140 Hz/pixel, with 3 ave
ages. At 7 T, the matrix size was 688  688 (0.3  0.3  1.5 mm
voxels), GRAPPA factor 2, turbo factor of 11 with 29 echo trains p
slice, TE/TR = 81/4500 milliseconds, FA = 147 degrees, bandwidth
140 Hz/pixel, 4 averages.
Protocols were adjusted to achieve a higher spatial resolution
7 T in the same acquisition time, while maintaining a similar CN
and image SNR which was acceptable for clinical use. Two repetition
of each sequence were carried out at both field strengths using a sphe
ical oil phantom for SNR calculation according to Dietrich et al.22
Evaluation of Adverse Effects
A questionnaire was completed by every patient after the MR
examination at the 2 field strengths. Each adverse effect was analyze2 www.investigativeradiology.com
                              Copyright © 2016 Wolters Kluwer Health, Inc. Unauthori
                              This paper can be cited using the date of access and thewith respect to duration of the symptom, intensity, requirement of fu
ther treatment, and relationship to medical device.
Quantitative Analysis
For each sequence, 2 readers independently selected regions
interest (ROIs) for SNR and CNR estimation. SNR was calculated
the mean signal intensity divided by the standard deviation in a hom
geneous WM area, which was not affected by any pathology. The sta
dard deviation of theWMsignalwas used as an estimate of noise (rath
than that in a background region) due to the lack of true backgroun
noise in DWI or MP2RAGE. A “voxel-volume-normalized” SN
was calculated for 7 T by multiplying the 7 T SNR values by the rat
of the 3 T and the 7 T voxel volumes to account for the effect of th
different resolutions used at the 2 field strengths.
In volunteers and patients with no visible pathology, the CN
was estimated as the difference between the mean signal of WM an
GM ROIs, divided by the standard deviation of the signal in WM.
SWI, a small vein (with a diameter slightly above the voxel size
3 T) was used instead of the GM ROI. In patients with visible patho
ogy, ROIs were placed within the pathology and in normal-appearin
WM, respectively. Mean SNR and CNR values were calculated for eac
cohort of volunteers and patients (grouped according to their patho
ogy). SNR and CNR results from both readers were combined usin
the following equations23:

Xc ¼ n1

X 1 þ n2 X 2
n1 þ n2 ½
σc ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n1 σ21 þ

X 1−

X c
 2
h i
þ n2 σ22 þ

X 2−

X c
 2
h i
n1 þ n
v
u
u
t ½
Where

X 1,

X 2, and

X c are the mean SNR or CNR from reader
2, and both readers combined. Similarly, σ1, σ2, and σc are the standa
deviations of SNR or CNR from reader 1, 2, and both readers com
bined. n1 and n2 represent the sample sizes of the cohorts from reade
1 and 2.
In the case of phantommeasurements, the SNR of each sequen
was estimated from a circular ROI at the center of the phantom. Tw
runs with the same sequencewere combined into a sum and a differen
image and SNR was calculated as the mean signal of the sum image d
vided by √2 and the standard deviation of the difference image, accor
ing to Dietrich et al.22
Semiquantitative Analysis—Diagnostic
Confidence Score
For each of the 4 disease groups, 3 pathology-specific imagin
criteria were assessed (see example evaluation sheet, Table 2). Two e
perienced radiologists specialized in neuroimaging (with 22 and 5 yea
of experience) were asked to rate their confidence level for the criteria
both field strengths. Assessment of images was performed indepe
dently, and in a random order for both field strengths and both reade
were blinded with regard to field strength.
The following criteria for the 4 disease groups were assessed:
1. Multiple sclerosis: lesion distribution pattern, CLs, presence of
central vein or iron deposits (CVID) within a lesion
2. Vascular disease: extension of WM changes (WMCs), CL
microbleeds (MBs)
3. Temporal lobe epilepsy: underlying pathologies—mesial tempor
sclerosis (MTS), malformations of cortical development (MCDs
vascular malformations, i.e. cavernomas in TLE or MBs.
4. Tumor: extra-axial versus intra-axial location (EA/IA), solitary ve
sus multiple (S/M), and benign versus malignant (B/M).© 2016 Wolters Kluwer Health, Inc. All rights reserved.
zed reproduction of this article is prohibited.                                                                   
 unique DOI number which can be found in the footnotes.
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TABLE 2. Example of an Evaluation Sheet Used for Vascular Disease Patients
Worksheet CUNI
Code NR CUNI Reader Prof Dr XXX XXX
Pathology Vascular Disease/Infarcts
Level of Confidence Description Microangiopathy/Extension of White Matter Changes Cortical Lesions Microbleeds
10 Definitely 1 or more lesions
9 Highly likely 1 or more lesions
8 Quite likely 1 or more lesions
7 Probably 1 or more lesions
6 Possibly 1 or more lesions
5 Small chance of 1 or more lesions
4 Possibly no lesion(s)
3 Probably no lesion(s)
2 Likely no lesion(s)
1 Definitely no lesion(s)
Image Quality Microangiopathy/Extension of White Matter Changes Cortical Lesions Microbleeds
I Poor
II Moderate, average
III Good
IV Excellent
Springer et al Investigative Radiology • Volume 00, Number 00, Month 2016
              
              The diagnostic confidence score (DCS),24 originally publishe
as a 5-point grading system, was extended to a 10-point grading syste
and in tumor diseasewas slightly adapted for all 3 criteria (Table 3). Th
DCSwas calculated by assigning different weighting factors to the co
fidence levels (Table 4).
The more patients with a high diagnostic certainty for th
disease-specific criterion are found (“definitely no lesion” and “def
nitely a lesion”), the higher the score of the examined disease-specif
criterion will be. This value is reduced by 1 count for each patient wi
a low diagnostic certainty (“small chance of 1 or more lesions”) regar
ing the examined disease-specific criterion. It is also reduced, but to
smaller amount (by 0.5, 0.375, or 0.25 counts) when the diagnos
was made with a high probability but not without doubt (“highly like
1 or more lesions,” “quite likely 1 or more lesions,” “probably 1 or moTABLE 3. The Confidence Levels for DCS as Published by Stahl et al24
Adapted for All 3 Criteria
Diagno
Vascular Disease, MS, TLE
Score Lesion Versus No Lesion Extra-Axial Versus Intra-Ax
10 Definitely 1 or more lesions Definitely intra-axial
9 Highly likely 1 or more lesions Highly likely intra-axial
8 Quite likely 1 or more lesions Quite likely intra-axial
7 Probably 1 or more lesions Probably intra-axial
6 Possibly 1 or more lesions Possibly intra-axial
5 Small chance of 1 or more lesions Small chance of being located int
4 Possibly no lesions Possibly extra-axial
3 Probably no lesions Probably extra-axial
2 Likely no lesions Likely extra-axial
1 Definitely no lesions Definitely extra-axial
DCS indicates diagnostic confidence score; MS, multiple sclerosis; TLE, temp
4 www.investigativeradiology.com
                              Copyright © 2016 Wolters Kluwer Health, Inc. Unauthori
                              This paper can be cited using the date of access and thelesions,” “possibly 1 or more lesions,” “possibly no lesions,” “probab
no lesions,” and “likely no lesions”). In summary, the higher the scor
the higher the global diagnostic confidence.
The score was calculated per patient. Scores were rounded to
decimal place.
Histopathology was available in 6 of 9 patients in the epilep
cohort after mesiotemporal lobectomy. Correlation with the criterio
diagnosis/exclusion of MTS was possible in 5 of the 9 cases due
the lack of a coronal T2-weighted sequence in 1 case. In the tumor c
hort, histopathology was available in 10 of 11 patients after tumor r
section. Correlation with the criterion “benign versus malignant” w
possible in 9 of the 10 cases, due to an ambiguous result in 1 patien
A metastatic lesion was proven by histopathology and throug
the administration of a conventional gadolinium-based contrast ageAdapted to a 10-Point Grading System and in Tumor Disease Slightly
stic Confidence
Tumor
ial
Solitary Lesion Versus
Multiple Lesions Benign Versus Malign
Definitely multiple Definitely malign
Highly likely multiple Highly likely malign
Quite likely multiple Quite likely malign
Probably multiple Possibly malign
Possibly multiple Possibly malign
ra-axial Small chance of being multiple lesions Small chance of being malign
Possibly solitary Possibly benign
Probably solitary Probably benign
Likely solitary Likely benign
Definitely solitary Definitely benign
oral lobe epilepsy.
© 2016 Wolters Kluwer Health, Inc. All rights reserved.
zed reproduction of this article is prohibited.                                                                   
 unique DOI number which can be found in the footnotes.
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TABLE 4. Calculation of the DCS by Assigning Different Weighting Factors to the Confidence Levels
DCS = Ndnl − 0.25  Nlnl − 0.5  Npnl − 0.75  Npossnl − Nsc1l − 0.75  Nposs1l − 0.5  Np1l − 0.375  Nql1l − 0.25  Nhl1l + Nd1l
Ndnl No. subjects with “definitely no lesions” of this criterion
Nlnl No. subjects with “likely no lesions” of this criterion
Npnl No. subjects with “probably no lesions” of this criterion
Npossnl No. subjects with “possibly no lesions” of this criterion
Nsc1l No. subjects with “small chance of 1 or more lesions” of this criterion
Nposs1l No. subjects with “possibly 1 or more lesions” of this criterion
Np1l No. subjects with “probably 1 or more lesions” of this criterion
Nql1l No. subjects with “quite likely 1 or more lesions” of this criterion
Nhl1l No. subjects with “highly likely 1 or more lesions” of this criterion
Nd1l No. subjects with “definitely 1 or more lesions” of this criterion
DCS indicates diagnostic confidence score.
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              within an MRI examination performed between 34 and 2 days befo
the examination at 3 T and 7 T MRI.
The intra-axial versus extra-axial location of a lesion was prove
by histopathology and by all available clinical data.
Based on the criterion standard, the accuracy of the diagnosis
both readers was calculated.TABLE 5. SNR and CNR Summary Statistics (Mean and Standard Dev
in Spatial Resolution (SNR adj)
Volunteers
SNR, Mean SNR, SD CNR, Mean CNR, S
T1 MP2RAGE 3D 3 T 61.2 18.2 30.8 9.5
7 T 34.8 7.6 17.8 4.7
T2 TSE 2D 3 T 22.0 7.6 12.4 5.5
7 T 16.5 3.9 11.7 3.3
FLAIR TSE 2D 3 T 25.4 7.7 11.6 5.7
7 T 16.8 6.4 11.2 3.7
T2* GRE 3 T 44.8 18.7 10.5 7.7
7 T 22.9 9.8 12.1 6.7
fMRI* 3 T 43.2 11.8 12.2 5.5
7 T 14.7 3.9 13.3 5.7
T2 SPACE 3D 3 T 28.1 9.2 4.7 2.6
7 T 33.1 7.3 8.6 4.8
FLAIR SPACE 3D 3 T 29.1 11.0 6.6 3.3
7 T 28.5 7.8 10.4 6.3
DWI single shot 3 T 15.2 2.9
7 T 22.6 7.5
DWI RESOLVE 3 T 17.9 3.2
7 T 12.8 2.3
T1 FLASH 3 T 94.6 12.2 14.0 3.8
7 T 84.2 31.6 11.8 7.5
DIR SPACE 3D 3 T 8.5 3.3 26.4 7.9
7 T 16.6 5.9 21.0 10.3
Blank spaces indicate no GM/WM contrast.
Results for healthy volunteers (left) and patients analyzed as healthy volunteer
*Please note that these volunteers are different than those considered for the re
SNR indicates signal-to-noise; CNR, contrast-to-noise ratio; MP2RAGE, magn
T2 TSE 2D, 2D turbo spin echo; FLAIR TSE 2D, 2D FLAIR TSE; T2* GRE, T2
weighted TSE with variable flip angle; FLAIR SPACE 3D, 3D FLAIRTSE with va
RESOLVE, multishot readout-segmented diffusion-weighted EPI with 2D navigato
3D, 3D double inversion recovery TSE with variable flip angle.
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Overall image quality was graded according to a 4-level scal
The amount of blurring and other artifacts, the contrast between cerebr
spinal fluid and parenchyma, GM-WMdifferentiation, and the amount
noise, were analyzed subjectively and independently by 2 radiologisiation Over 2 Readers) and SNR Values Adjusted for Relative Difference
Patients Analyzed as Volunteers
D SNR adj SNR, Mean SNR, SD CNR, Mean CNR, SD SNR adj
61.2 57.0 17.0 29.5 17.5 57.0
49.5 35.9 8.3 18.8 10.1 51.2
22.0 21.8 6.7 13.8 7.1 21.8
42.9 15.4 5.3 10.5 6.0 40.2
25.4 24.2 5.7 11.5 5.8 24.2
28.0 17.3 10.3 10.7 8.1 28.9
44.8 40.9 15.3 16.1 18.7 40.9
176.4 18.9 5.7 12.1 6.6 145.9
43.2
73.8
28.1 23.1 8.6 6.4 9.7 23.1
36.7 27.4 9.6 12.4 14.6 30.5
29.1 30.2 11.0 7.3 11.0 30.2
63.9 31.6 12.6 13.6 13.8 70.8
15.2 15.3 2.3 15.3
37.6 18.4 4.8 30.7
17.9 15.6 3.3 15.6
33.3 11.1 2.4 28.9
94.6 86.9 24.5 19.7 23.5 86.9
175.3 80.3 31.8 13.9 17.9 167.3
8.5 9.3 4.5 17.0 8.7 9.3
33.2 15.7 6.2 16.2 11.8 31.3
s, that is, without visible pathology (right).
maining 10 sequences, as described in Materials and Methods.
etization prepared rapid acquisition gradient echo sequence with bias field correction;
*-weighted gradient echo sequence; fMRI, functional MRI; T2 SPACE 3D, 3D T2-
riable flip angle; DWI single shot, single-shot diffusion-weighted imaging EPI; DWI
r correction; T1 FLASH, T1-weighted spoiled gradient echo sequence; DIR SPACE
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              The image quality score was assessed taking into account whether or n
diagnostic decision making was hampered by artifacts, for example, m
tion artifacts, or by thewell-known coil-related signal decrease in the po
terior fossa. Images graded as 1 had poor quality (limited diagnost
information, severe artifacts), and images graded as 4 had excellent im
age quality (eg, good diagnostic quality, minor, or no artifacts).
Statistical Analysis
All statistical computations were performed using IBM SPS
Statistics for Windows Version 22.0.0.1 and N-Query-Advisor 7.0.
Assuming a medium effect (epsilon = 0.47) and a dropout rate
5%, 40 patients were necessary to obtain a power of 80% (type 2 err
of 20%) using a 2-tailed α level of 5%.
Metric data, such as SNR and CNR, are described using mea
and standard deviation, DCS in absolute numbers. To compare 3
and 7 T, paired Student t tests were performed. Because of the rel
tively small sample size, no multiplicity corrections were performe
to avoid increasing error of the second type.
A P value equal to or below 0.05 was considered to indica
significant results.
Moderation effects were calculated. The interobserver variab
ity was expressed through absolute and relative values of interobserv
agreement.
RESULTS
Quantitative Analysis
Summary statistics for SNR and CNR and voxel-volume-adjuste
SNR estimations for volunteers and patients are presented in Tables
6, and 7. Because of reconstruction errors in 3 healthy subjects (subjecTABLE 6. SNR and CNR Summary Statistics (Mean and Standard Dev
Epilepsy
SNR, Mean SNR, SD CNR, Mean CNR, S
T1 MP2RAGE 3D 3 T 60.6 23.6 30.0 20.5
7 T 33.8 10.2 20.4 8.7
T2 TSE 2D 3 T 21.6 5.2 31.3 30.8
7 T 13.9 4.0 24.7 13.8
FLAIR TSE 2D 3 T 24.7 10.4 11.1 6.2
7 T 16.5 7.6 13.4 5.6
T2* GRE 3 T 50.4 29.3 7.4 5.3
7 T 20.1 5.4 2.8 2.2
T2 SPACE 3D 3 T 27.5 7.7 20.0 14.9
7 T 32.4 8.7 17.9 18.7
FLAIR SPACE 3D 3 T 30.7 11.3 14.4 8.7
7 T 30.9 8.7 11.7 7.0
DWI single shot 3 T 17.8 5.7 14.2 9.9
7 T 19.3 8.0 18.3 14.9
DWI RESOLVE 3 T 17.6 3.6 12.6 14.5
7 T 11.4 3.8 11.9 8.0
T1 FLASH 3 T 69.1 18.5 11.2 8.7
7 T 75.2 40.8 10.6 7.2
DIR SPACE 3D 3 T 13.8 4.3 16.4 8.9
7 T 19.9 8.8 12.4 9.9
Patient SNR and CNR results were grouped by pathology.
SNR indicates signal-to-noise; CNR, contrast-to-noise ratio; MP2RAGE, magn
T2 TSE 2D, 2D turbo spin echo; FLAIR TSE 2D, 2D FLAIR TSE; T2* GRE, T2
weighted TSE with variable flip angle; FLAIR SPACE 3D, 3D FLAIRTSE with va
RESOLVE, multishot readout-segmented diffusion-weighted EPI with 2D navigato
3D, 3D double inversion recovery TSE with variable flip angle.
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                              This paper can be cited using the date of access and the6, 8, and 10), SWI images were not available. These were therefore n
included in the SNR and CNR calculation. If no correction for the di
fering voxel sizes was applied, SNR valueswere higher for the measur
ments at 3 T (which were lower resolution). Exceptions, with high
SNR at 7 T despite higher spatial resolution, were for T2 SPACE 3D
DWI single shot, and DIR SPACE 3D images. The 7 T/3 T ratios
voxel-volume-adjusted SNR estimations in the phantom and in viv
measurements are summarized in Table 8. Results for DWI are n
included for the phantom, as this was not suited to measurements
diffusion. Signal-to-noise ratio corrected by the ratio of 3 T/7 T voxel si
was higher at 7 T than at 3 T in 10 of 11 sequences (the exception being T
MP2RAGE3D) involunteers and all patient groups. The samewas true f
the phantom, in which SNR was assessed according to Dietrich et al.
Average CNR values were broadly comparable at 3 T and 7 T
volunteers and in patients. Exceptions were higher CNR at 3 Twith T
MP2RAGE 3D and generally slightly higher CNR at 7 T with T
SPACE 3D and FLAIR TSE 2D. The CNR standard deviations we
of the same order of magnitude as the average CNR values themselve
however, as readers generally selected different pathologies for evalu
tion. In DWI sequences (single shot and RESOLVE) in volunteers an
those patients analyzed in the sameway as volunteers (novisible patho
ogy), CNR values were not calculated because in diffusion-weighte
images there was, as it is well known, no clear GM/WM contrast.
Semiquantitative Analysis—Diagnostic
Confidence Score
The overall diagnostic confidence of both readers (absolute DC
values in brackets next to DCS values per patient) was higher at 7
compared with 3 T (Table 9). Interrater agreement was 69.7% at 3
and 93.3% at 7 T.iation Over 2 Readers) and Adjusted SNR Values (SNR adj)
Multiple Sclerosis
D SNR adj SNR, Mean SNR, SD CNR, Mean CNR, SD SNR adj
60.6 61.4 25.1 35.3 12.9 61.4
48.1 32.1 5.2 21.0 5.5 45.7
21.6 20.2 4.3 23.8 8.3 20.2
36.3 17.2 5.8 22.3 10.8 44.8
24.7 23.5 7.6 20.6 7.0 23.5
27.6 16.9 5.1 18.9 12.0 28.2
50.4 53.0 13.1 7.7 5.0 53.0
154.9 24.7 5.7 4.2 2.6 190.8
27.5 25.6 9.4 12.5 4.0 25.6
36.0 32.2 16.0 13.6 9.2 35.8
30.7 31.5 10.7 13.4 5.8 31.5
69.5 28.3 11.7 10.3 9.1 63.5
17.8 17.8 3.7 10.9 3.7 17.8
32.2 20.8 9.7 12.6 5.6 34.7
17.6 16.0 2.9 9.3 2.6 16.0
29.9 12.2 4.9 7.7 3.0 31.7
69.1 77.8 15.3 8.5 3.5 77.8
156.7 76.6 29.8 8.3 8.7 159.5
13.8 12.3 5.5 35.5 15.5 12.3
39.8 16.9 6.9 23.5 14.6 33.7
etization prepared rapid acquisition gradient echo sequence with bias field correction;
*-weighted gradient echo sequence; fMRI, functional MRI; T2 SPACE 3D, 3D T2-
riable flip angle; DWI single shot, single-shot diffusion-weighted imaging EPI; DWI
r correction; T1 FLASH, T1-weighted spoiled gradient echo sequence; DIR SPACE
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TABLE 7. SNR and CNR Summary Statistics (Mean and Standard Deviation Over 2 Readers) and Adjusted SNR Values (SNR adj)
Tumor Vascular Disease
SNR, Mean SNR, SD CNR, Mean CNR, SD SNR adj SNR, Mean SNR, SD CNR, Mean CNR, SD SNR adj
T1 MP2RAGE 3D 3 T 51.4 14.7 29.5 14.3 51.4 44.9 14.8 30.7 12.2 44.9
7 T 32.3 10.9 20.2 11.5 46.0 27.4 9.7 19.9 8.1 39.0
T2 TSE 2D 3 T 18.7 4.7 40.7 27.7 18.7 16.3 8.1 34.7 25.3 16.3
7 T 12.5 2.5 24.2 13.3 32.6 12.8 5.6 29.1 20.8 33.4
FLAIR TSE 2D 3 T 23.6 6.2 34.4 37.0 23.6 20.7 5.5 17.4 3.9 20.7
7 T 14.4 4.3 18.0 11.5 24.0 13.4 2.6 16.7 11.3 22.4
T2* GRE 3 T 31.6 13.7 12.9 13.2 31.6 32.0 23.1 8.3 5.3 32.0
7 T 15.7 4.6 4.8 2.8 121.1 18.3 8.5 6.9 4.6 141.2
T2 SPACE 3D 3 T 19.5 8.8 17.7 11.6 19.5 17.3 6.8 17.1 9.4 17.3
7 T 25.7 11.3 21.0 14.7 28.5 26.8 11.8 13.0 11.4 29.8
FLAIR SPACE 3D 3 T 30.8 9.9 15.9 7.8 30.8 27.7 10.6 16.7 12.6 27.7
7 T 26.3 13.6 8.0 7.5 59.0 31.0 7.6 13.0 13.2 69.7
DWI single shot 3 T 15.3 3.3 19.1 11.0 15.3 16.1 4.7 17.1 8.4 16.1
7 T 15.1 4.3 17.4 10.4 25.2 11.3 4.7 11.4 5.8 18.9
DWI RESOLVE 3 T 12.6 4.3 15.7 10.9 12.6 13.6 2.9 12.6 5.6 13.6
7 T 9.7 2.8 11.5 4.3 25.3 7.3 1.5 8.4 2.2 19.0
T1 FLASH 3 T 71.2 11.2 24.4 26.0 71.2 71.8 29.0 18.2 11.8 71.8
7 T 60.0 21.7 10.3 11.3 125.1 63.4 31.3 7.0 5.0 132.1
DIR SPACE 3D 3 T 8.7 2.8 29.1 22.3 8.7 11.3 6.0 19.6 7.1 11.3
7 T 12.5 6.4 18.3 11.8 25.0 15.6 5.3 20.0 20.1 31.2
Patient SNR and CNR results were grouped by pathology.
SNR indicates signal-to-noise; CNR, contrast-to-noise ratio; MP2RAGE, magnetization prepared rapid acquisition gradient echo sequence with bias field correction;
T2 TSE 2D, 2D turbo spin echo; FLAIR TSE 2D, 2D FLAIR TSE; T2* GRE, T2*-weighted gradient echo sequence; fMRI, functional MRI; T2 SPACE 3D, 3D T2-
weighted TSE with variable flip angle; FLAIR SPACE 3D, 3D FLAIRTSE with variable flip angle; DWI single shot, single-shot diffusion-weighted imaging EPI; DWI
RESOLVE, multishot readout-segmented diffusion-weighted EPI with 2D navigator correction; T1 FLASH, T1-weighted spoiled gradient echo sequence; DIR SPACE
3D, 3D double inversion recovery TSE with variable flip angle.
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              Diagnostic Confidence Score for Vascular Disease
The DCS for the assessment of the 3 diagnostic criteria in vasc
lar disease (Table 10) at 3 T for reader 1 was 0.3 (8.1), and for reader
was 0.4 (10.0). At 7 T, the DCS was 0.7 (17.9) for both readers. Dia
nostic confidence score values showed significant differences betweeTABLE 8. Comparison of 7 T/3 T SNRs Calculated From Phantom and
Phantom Volunteers Patients Analyzed as V
T1 MP2RAGE 3D 0.8 0.8 0.9
T2 TSE 2D 2.2 2.0 1.8
FLAIR TSE 2D 1.5 1.1 1.2
T2* GRE 2.5 3.9 3.6
fMRI 1.3 1.7
T2 SPACE 3D 1.4 1.3 1.3
FLAIR SPACE 3D 2.1 2.2 2.3
DWI single shot 2.5 2.0
DWI RESOLVE 1.9 1.9
T1 FLASH 4.2 1.9 1.9
DIR SPACE 3D 4.2 3.9 3.4
SNR indicates signal-to-noise; MP2RAGE, magnetization prepared rapid acqu
echo; FLAIRTSE 2D, 2D FLAIRTSE; T2*GRE, T2*-weighted gradient echo seq
angle; FLAIR SPACE 3D, 3D FLAIR TSE with variable flip angle; DWI sing
readout-segmented diffusion-weighted EPI with 2D navigator correction; T1 FLA
sion recovery TSE with variable flip angle.
© 2016 Wolters Kluwer Health, Inc. All rights reserved.
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                              This paper can be cited using the date of access and thethe 2 field strengths (P = 0.03) and between the 3 disease-specif
criteria (P = 0.016). No significant moderation effects were observe
Interrater agreement was 81.5% at 3 T and 100% at 7 T.
There was no significant difference in diagnostic confiden
between the 2 observers in the evaluation of the extent of WMCsIn Vivo Estimations
7 T/3 T SNRs
olunteers Epilepsy Multiple Sclerosis Tumor Vascular Disease
0.8 0.7 0.9 0.9
1.7 2.2 1.7 2.0
1.1 1.2 1.0 1.1
3.1 3.6 3.8 4.4
1.3 1.4 1.5 1.7
2.3 2.0 1.9 2.5
1.8 1.9 1.6 1.2
1.7 2.0 2.0 1.4
2.3 2.1 1.8 1.8
2.9 2.7 2.9 2.8
isition gradient echo sequence with bias field correction; T2 TSE 2D, 2D turbo spin
uence; fMRI, functionalMRI; T2 SPACE 3D, 3D T2-weighted TSEwith variable flip
le shot, single-shot diffusion-weighted imaging EPI; DWI RESOLVE, multishot
SH, T1-weighted spoiled gradient echo sequence; DIR SPACE 3D, 3D double inver-
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TABLE 9. Diagnostic Confidence Scores of 2 Readers at Both
Field Strengths for the 4 Disease Groups for All Patients (A) and
Per Patient (B)
A 3 T 7 T
Reader 1 Reader 2 Reader 1 Reader 2
VD 8.1 9.9 17.9 17.9
MS 4.3 3.5 18.9 17.0
TLE 5.6 12.6 18.1 16.9
Tumor 15.8 21.5 20.5 22.8
B 3 T 7 T
Reader 1 Reader 2 Reader 1 Reader 2
VD 0.3 0.4 0.7 0.7
MS 0.1 0.3 0.6 0.5
TLE 0.2 0.5 0.7 0.6
Tumor 0.5 0.7 0.6 0.7
MS indicates multiple sclerosis; VD, vascular disease; TLE, temporal lobe
epilepsy.
TABLE 10. Diagnostic Confidence Scores of 2 Readers at Both
Field Strengths for Vascular Disease for All Patients (A) and Per
Patient (B); Diagnostic Confidence Scores of 2 Readers at Both
Field Strengths for MS for All Patients (C) and Per Patient (D)
A 3 T 7 T
Reader 1 Reader 2 Reader 1 Reader 2
WMC 6.3 6.5 6.5 6.5
CL −3.3 −1.8 3.6 3.6
MB 5.1 5.3 7.8 7.8
VD 8.1 10.0 17.9 17.9
B 3 T 7 T
Reader 1 Reader 2 Reader 1 Reader 2
WMC 0.7 0.7 0.7 0.7
CL −0.4 −0.2 0.4 0.4
MB 0.6 0.6 0.9 0.9
VD 0.3 0.4 0.7 0.7
C 3 T 7 T
Reader 1 Reader 2 Reader 1 Reader 2
LDP 11 11 11 11
CL −4.3 −4.8 −0.6 −0.6
CVID −2.5 3.6 8.5 7.1
MS 4.3 9.9 18.9 17.5
D 3 T 7 T
Reader 1 Reader 2 Reader 1 Reader 2
LDP 1.0 1.0 1.0 1.0
CL −0.4 −0.4 −0.1 −0.1
CVID −0.2 0.3 0.8 0.6
MS 0.1 0.3 0.6 0.5
MS indicates multiple sclerosis; VD, vascular disease; WMC, white matter
changes; CL, cortical lesions; MB, microbleeds; LDP, lesion distribution pattern;
CVID, central vein or iron deposits.
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              vascular disease. The DCS was statistically significantly higher at 7
for the diagnosis and exclusion of CLs in vascular disease (P = 0.01
for reader 1, P = 0.036 for reader 2). The DCS was higher at 7 T f
the diagnosis of MBs in vascular disease; however, this was not a stati
tically significant effect.
Diagnostic Confidence Score for Multiple Sclerosis
The DCS for the assessment of the 3 diagnostic criteria
MS (Table 10) at 3 T for reader 1 was 0.1 (4.3) and for reader 2 0
(9.9). At 7 T, the DCS was 0.6 (18.9) for reader 1 and 0.5 (17.5) f
reader 2. Diagnostic confidence score values showed significant di
ferences between the 2 field strengths (P < 0.001), and between th
3 criteria (P < 0.001). Moderation effects to the method were “rate
(P = 0.013) and “criteria” (P = 0.015), and the triple interaction rater
method criteria showed that the influence of the criteria on the diffe
ence between the DCS scores at the 2 field strengths was different b
tween the 2 raters (P = 0.007). Interrater agreement was 63.6% at 3
and 93.9% at 7 T.
There was no difference in diagnostic confidence in the evalu
tion of the distribution pattern of MS lesions. There was a tendenc
for the DCS to be higher at 7 T for the diagnosis and exclusion
CLs in MS (Fig. 1). The DCS for depicting the central vein or iron a
cumulations within a lesion in MS was statistically significantly high
at 7 T for reader 1 (P < 0.001), and for reader 2, therewas a tendency f
the DCS to be higher at 7 T (P = 0.068; Fig. 2).
Diagnostic Confidence Score for Temporal
Lobe Epilepsy
The DCS values for the assessment of the 3 possible underlyin
pathologies for temporal lobe epilepsy (Table 11) at 3 Twere 0.2 (5.
for reader 1 and 0.5 (12.6) for reader 2. At 7 T, the DCS was 0
(18.1) for reader 1 and 0.6 (16.9) for reader 2. No significant moder
tion effects were observed. Interrater agreement was 57.7% at 3 T an
92.3% at 7 T.
The DCS for the diagnosis and exclusion of MTS with regard
which subunits of the hippocampus were affected was higher at 7
however, this was not statistically significant (Fig. 3). In 3 patient case
both readers expressed slightly less confidence at 7 T for the diagnos
of MTS with regard to the lesioned subunits of the hippocampus due
motion artifacts in the 7 T images. The accuracy of both raters for dia
nosis and exclusion of MTS, using both field strengths, was 100%. F8 www.investigativeradiology.com
                              Copyright © 2016 Wolters Kluwer Health, Inc. Unauthori
                              This paper can be cited using the date of access and thethe diagnosis and exclusion of MCD, the DCS was higher at 7 T; f
reader 1, there was a tendency for the DCS to be higher at 7 T (P
0.097), and there was no statistically significant difference observe
for reader 2. The DCSwas higher at 7 T for the diagnosis and exclusio
of vascular malformations and MBs in temporal lobe epilepsy; f
reader 1, the difference between the 2 field strengths was statistical
significant (P = 0.035); however, there was no statistically significa
difference for reader 2.
Diagnostic Confidence Score for Tumor
The DCS values for the assessment of the 3 diagnostic criter
for brain tumors (Table 11) at 3 Twere 0.5 (15.8) for reader 1 and 0
(21.5) for reader 2. At 7 T, the DCS was 0.6 (20.5) for reader 1 an
0.7 (22.8) for reader 2. Diagnostic confidence score values showed si
nificant differences between the 3 criteria (P = 0.043). No significa
moderation effects were observed. Interrater agreement was 75.8%
3 T and 87.9% at 7 T.
The DCS for the assignment of a lesion to an extra-axial vers
an intra-axial location was higher at 7 T, but this was not a statistical
significant effect. The DCS for the evaluation of whether a lesion w
singular or multiple was higher at 7 T, although this was not statistical
significant. The DCS for evaluating whether a tumor was benign or m
lignant was higher at 7 T, although this was not a statistically significa
effect (Fig. 4).© 2016 Wolters Kluwer Health, Inc. All rights reserved.
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FIGURE 1. Sagittal MP2RAGE of an MS patient acquired at 3 T (A) and 7 T (C), and corresponding sagittal 3D DIR acquired at 3 T (B) and 7 T (D). Two
intracortical lesions—type II neocortical lesions7 (green arrow)—next to a subcortical lesion (red arrow) aremore clearly depicted at 7 T. Figure 1 can be
viewed online in color at www.investigativeradiology.com.
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              In 10 of 11 patients in our brain tumor cohort, histopatholog
was available.
For the criterion “extra-axial versus intra-axial location of the l
sion,” the accuracy of both raters was 100% at both field strengths.
For the criterion “singularity versus multiplicity of lesions
reader 1 assessed, in 1 case, at both field strengths, a singular metastas
as multiple metastases, due to different weighting of a small cortica
subcortical lesion on noncontrast imaging. The accuracy of reader
was 90% using both field strengths, and the specificity of reader 1 r
garding the multiplicity of a lesion at both field strengths was 85.7%
The accuracy of reader 2 was 100% at both field strengths.
For the criterion “benign versus malignant lesion” reader 1, in
case, at 3 T assessed a malignant lesion as benign, and at 7 T, reader
achieved the correct rating, retrospectively, due to the better visualizatio
of neoangiogenesis inmalignant brain tumors through SWI imaging. Th
accuracy of reader 1 was 88.9% using 3 T, and the sensitivity regardin
the benignity of a lesion was 83%. The accuracy of reader 1 was 100
using 7 T, and that of reader 2 was 100% at both field strengths.ty
ld
e
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erImage Quality
There was no significant difference in the overall image quali
score between 3 T and 7 T, with values of 3.8 for reader 1 at both fie
strengths, 3.6 for reader2at3T, and3.7 for reader2at7T,where the imag
quality score was assessed on the basis of whether or not diagnost© 2016 Wolters Kluwer Health, Inc. All rights reserved.
                              Copyright © 2016 Wolters Kluwer Health, Inc. Unauthori
                              This paper can be cited using the date of access and thedecisionmakingwas hampered by artifacts, for example,motion artifac
or by thewell-known coil-related signal decrease in the posterior fossa.
Adverse Effects
Fourteen subjects experienced dizziness during the examinatio
at 7 T; 1 of these experienced additional nausea. The duration of th
symptoms was less than 30 minutes in all cases. The intensity of th
symptom dizziness was graded moderate by the patient who also expe
enced nausea; nausea in this patient was mild. By all other 13 patien
who experienced dizziness during the 7 T examination, this sympto
was graded as being mild. In all 14 cases, the symptom dizziness w
possibly related to the medical device. No further treatment was nece
sary in all cases. No further adverse effects were observed.
No adverse effects were observed during the examination at 3
DISCUSSION
In this study, we aimed to compare quantitative and semiquan
tative parameters (SNR, CNR, image quality, diagnostic confidence)
standard brain MRI examinations, with comparable sequence par
meters and similar scan time at 3 Tand 7 T, for the evaluation of 4 com
mon disease groups of the brain, with a focus on 3 important imagin
criteria in each group.
As a main finding, this study demonstrated overall higher DCS
at 7 T compared with 3 T. This is mainly due to the higher spati
resolution, which can be achieved at 7 T, as evidenced by highwww.investigativeradiology.com 9
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FIGURE 2. Axial T2-weighted images of anMSpatient acquired at 3 T (A) and 7 T (C), and corresponding axial SWI images acquired at 3 T (B) and 7 T (D).
Note the central vessels and iron deposits (rims) within MS lesions in SWI images (B and D, white arrows). In T2-weighted images central vessels are
challenging to depict (A and C, white arrows).
Springer et al Investigative Radiology • Volume 00, Number 00, Month 2016
              
              voxel-volume-normalized SNR in the same scan time, and due to th
higher phase contrast at 7 T. The higher SNR at 7 T can be investe
in higher spatial resolution at 7 T in comparison to 3 T in the same tim
Selection Criteria for the Patients
Our aim was to cover relevant clinical questions for the neur
radiologist in her/his daily clinical setting.25 Preselection required a
ceptance of an MRI examination that consisted of a protocol of 1
sequences, which required 1 hour at both field strengths. Patients
an emergency setting were thus excluded from the study.
Diagnostic Confidence Score
We selected the DCS24 to quantify the intraindividual diagnost
confidence of a reader with respect to diagnosis and also to exclusion
a lesion and with respect to assessing a particular criterion for a diseas
This approachwas designed to illustrate the intraobserver variability b
tween the 2 field strengths. Every rating concerning either diagnost
confidence of diagnosis or exclusion of a lesion or concerning the a
sessment of a criterion had an impact on the score.10 www.investigativeradiology.com
                              Copyright © 2016 Wolters Kluwer Health, Inc. Unauthori
                              This paper can be cited using the date of access and theInterobserver differences between ratings at 7 T and 3 T we
assessed retrospectively by 1 rater, whether the factor “measuremen
or the factor “rater“ himself/herself was the reason for the discrepanc
This was achieved by comparing the assessments of the 2 raters to th
criterion standard histopathology, which was available in nearly ha
of the cases. The factor “measurement” comprised the 2 different fie
strengths, as well as different measurement parameters. The fact
“rater” included different interpretation and weighting of patholog
findings, as well as missed findings and misdiagnosis.
In our study, the slightly higher accuracy at 7 T compared with
criterion standard and the higher interrater agreement at 7 T compare
with 3 T may also demonstrate the overall higher diagnostic confiden
at 7 T.
Demyelinating Disease—Multiple Sclerosis
In our study, the diagnostic confidence for the diagnosis of M
with regard to the dissemination in space,26 did not differ between the
readers at either field strength. However, Filippi et al27 outlined the be
ter visualization of WM lesions and their morphological characteristi© 2016 Wolters Kluwer Health, Inc. All rights reserved.
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TABLE 11. Diagnostic Confidence Scores of 2 Readers at Both
Field Strengths for TLE for All Patients (A) and Per Patient (B);
Diagnostic Confidence Scores of 2 Readers at Both Field Strengths
for Tumor for All Patients (C) and Per Patient (D)
A 3 T 7 T
Reader 1 Reader 2 Reader 1 Reader 2
MTS/SU 0.3 3.0 4.1 4.1
MCD 1.4 1.9 5.0 3.8
VMMB 4.0 7.8 9.0 9.0
TLE 5.6 12.6 18.1 16.9
B 3 T 7 T
Reader 1 Reader 2 Reader 1 Reader 2
MTS/SU 0.0 0.4 0.5 0.5
MCD 0.2 0.2 0.6 0.4
VMMB 0.4 1.0 0.9 1.0
TLE 0.2 0.5 0.7 0.6
C 3 T 7 T
Reader 1 Reader 2 Reader 1 Reader 2
EA/IA 7.3 9.8 9.8 11
S/M 7.0 8.5 7.3 8.5
B/M 1.5 3.3 3.5 3.3
Tumor 15.8 21.5 20.5 22.8
D 3 T 7 T
Reader 1 Reader 2 Reader 1 Reader 2
EA/IA 0.7 0.9 0.9 1.0
S/M 0.6 0.8 0.7 0.8
B/M 0.1 0.3 0.3 0.3
Tumor 0.5 0.7 0.6 0.7
MCD indicates malformation of cortical development; MTS/SU, mesial
temporal screlosis/subunits; VMMB, vascular malformations or microbleeds;
TLE, temporal lobe epilepsy; EA/IA, extra-axial versus intra-axial location;
S/M, solitary versus multiple; B/M, benign versus malignant.
FIGURE 3. Coronal T2-weighted images at 3 T (A andB) and7T (CandD) of
Neuronal loss in hippocampal subfields CA1, CA3, andCA4. Hippocampal su
Corresponding histopathological correlate, NeuN staining (E). Figure 3 can be
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© 2016 Wolters Kluwer Health, Inc. All rights reserved.
                                            Copyright © 2016 Wolters Kluwer Health, Inc. Unauthori
                                            This paper can be cited using the date of access and theat 7 T. Kollia et al reported in their comparative study, which was pe
formed with 1.5 T and 7 T, that WM lesions were better detected an
delineated from adjacent structures at 7 T and that, in 42% of the p
tients, additional lesions were detected at 7 T.
There was a nonsignificant tendency of the DCS for the diagn
sis and exclusion of CLs in MS to be higher at 7 T. Because of th
higher resolution at 7 T, primarily of the MP2RAGE sequence, but al
of the 3D DIR sequence, lesions can be more exactly assigned as bein
cortically, cortically-subcortically, or purely subcortically located. Th
finding is supported by a study by Tallantyre et al,29 in which hig
resolution 7 T imaging appeared useful for confidently classifying th
location of lesions in relation to the cortical/subcortical boundar
mainly through MPRAGE. Furthermore, our data are consistent wi
a study by de Graaf et al,18 where increased lesion detection was o
served in cortical GM at 7 T.
In the study presented here, the diagnostic confidence w
higher at 7 T for depicting a central vein and for detecting iron deposi
within an MS lesion—for 1 reader with a statistically significant effe
and for the other reader with a tendency toward a statistically significa
effect. Our findings are largely in agreement with the results of sever
other previously reported studies, which have demonstrated that a ce
tral vessel in an MSWM lesion can be depicted more clearly using 7
SWI than at 3 T,19 and that the presence of a central blood vessel can b
helpful in the differentiation of MS and microangiopathic lesions.30d
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The higher diagnostic yield for the diagnosis of MTS at 7 T, an
for the higher confidence in this diagnosis toward assignment to the hi
tologic subtype according to the ILAE consensus classification of hi
pocampal sclerosis31 at 7 T, is primarily due to the higher spati
resolution at 7 T, namely, in the coronal T2 TSE 2D sequence. Depen
ing on the protocol used, spatial resolutions of up to 100 μm,32 alon
with a slice thickness of 0.7 to 3 mm, can be achieved on T
weighted images in vivo.15,33 Our results are supported byWisse et al,
who showed that it is possible to delineate the main subfields of the hi
pocampal formation along its full length in vivo at 7 T MRI. Althoug
the hippocampus is located relatively close to the base of the skull, th
fast spin-echo sequences used in our study were very robust again
susceptibility artifacts in this region.
Improved GM/WM contrast and higher resolution at 7 T in th
MP2RAGE sequence34 leads to better GM/WM differentiation. Thiapatient suffering from left-sidedMTS type1.Mediumheight of hippocampus.
bfield CA2 is not affected (red arrow), and this ismore clearly depicted at 7 T.
viewed online in color at www.investigativeradiology.com.
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FIGURE 4. Axial FLAIR images of a glioblastomamultiforme acquired at 3 T (A) and 7 T (C), and corresponding axial SWI images acquired at 3 T (B) and 7 T
(D). Note the microvascularization of the tumor on the SWI sequence. Note also the hyperintense rim on 7 T FLAIR images (C) at the pial surface of the
cerebral cortex, which, as is well known, corresponds to layers I to III of the cortex. At 7 T, fat suppression on FLAIR imageswas not useddue to SAR limitations.
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              in our assessment, seemed to be helpful mainly for exclusion but als
diagnosis of MCD; however, the difference did not reach statistic
significance.ce
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dCerebrovascular Disease
There was no significant difference in diagnostic confiden
for the evaluation of the extension of WMCs in vascular diseas
Our findings are in agreement with Theysohn et al,35 who stated th
FLAIR images at 7 T highlighted WMLs known from 1.5 T to
comparable extent.
Diagnostic confidence score was significantly higher at 7 T f
the diagnosis and exclusion of CLs in vascular disease. Because
the higher resolution at 7 T, primarily of the MP2RAGE sequenc
but also of the 3D DIR sequence, lesions can be more exactly assigne
as being cortically, cortically-subcortically, or purely subcortically l
cated. In a study by van Veluw et al, the potential of ultra–high-fie
MRI to detect in vivo cortical microinfarcts was demonstrated.812 www.investigativeradiology.com
                              Copyright © 2016 Wolters Kluwer Health, Inc. Unauthori
                              This paper can be cited using the date of access and theDiagnostic confidence was higher at 7 T for the diagnosis an
exclusion of vascular malformations and MBs, presumably due to th
higher spatial resolution, but this was not statistically significant. Th
finding is consistent with Conijn at al,36 who found that the presen
and number of detected MBs are higher and also that the reliability
the detection of MBs improves with a 3D dual echo T2*-weighte
sequence at 7 T, compared with a 3D T2*-weighted sequence at 1.5
Tumor
In our study, diagnostic confidence was slightly higher at 7 T r
garding the extra-axial or intra-axial location of brain tumors, but th
was not statistically significant. In 1 case, a better visualization
displaced subarachnoid vessels at 7 T helped to define the extra-axi
location of the tumor.
In tumors, a higher confidence for the assessment of the mali
nancy of brain tumors was observed at 7 T, based on the better visualiz
tion of neoangiogenesis in malignant brain tumors; however, this resu
was not statistically significant. In addition to contrast-enhance© 2016 Wolters Kluwer Health, Inc. All rights reserved.
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              techniques, efforts have been made to use non–contrast-enhance
approaches, such as, for example, 3D SWI at 7 T in brain tumors to v
sualize intratumoral structures in brain gliomas, including themicrova
culature. Grabner et al37 found that 7 T SWI seems to be an appropria
method for the investigation of changes in brain tumor vascularizatio
under antiangiogenic therapy. Di Ieva et al14 used an objective quantif
cation by applying computer-aided fractal image analysis in 36 patien
with brain gliomas (grades II-IV), scanned at 7 T, to differentiate b
tween low-grade and high-grade gliomas.
Image Quality
There was no significant difference in the overall image quali
score between 3 T and 7 T, where the image quality score was assesse
on the basis of whether or not diagnostic decision making was ham
pered by artifacts. There was a small increase in artifacts at 7 T com
pared with 3 T. This can be attributed, in the main, to the high
resolution of the 7 T sequences but could also be affected by patient m
tion, which can be larger in the longer 7 T magnet bore.2
Some challenges still remain at 7 T. The T2 SPACE 3D and 3
FLAIR SPACE sequences at 7 T are still a challenge, as in our exper
ence these sequences have inherently higher B1 inhomogeneity, b
also because of the prolonged relaxation times at 7 T compared wi
3 T. T2-weighted 3D sequences with long echo trains with variable fl
angles (such as SPACE) - low SAR alternatives to standard T
weighted sequences at 7 T - are in the process of being optimized f
resolution, SNR, and CNR. Deficiencies in the 3D FLAIR SPAC
and T2 SPACE 3D sequence at 7 T did not hamper diagnostic decisio
making, however, as the 3D DIR sequence was used for diagnosis an
exclusion of CLs. In contrast to our experience with the 3D DIR spa
sequence, in the study by Tallantyre et al,29 not only the development
a 3D FLAIR sequence, but also of a 3D DIR sequence at 7 Twas d
scribed as problematic, primarily because of the inherent B1 inhomog
neity, but also because of the longer relaxation times at 7 T. As
consequence, in the study of van Veluw et al,8 the temporal lob
proved difficult to assess in the 7 T 3D FLAIR sequence because of
low SNR in these areas, which is a current known limitation of the a
plied 3D FLAIR sequence at 7 T. This is in accordance with our exp
rience and had also been shown in a study by Visser et al.38 In o
experience, the 3D DIR sequence profits highly from the possibili
to increase resolution at 7 T. We also noticed a slight decrease in hype
intense signal of cortex and lesions (WM lesions as well as CLs) com
pared with 3 T. Optimization work still has to be performed
determine optimum inversion times and flip angles.
In our experience also for the T1 FLASH sequence at 7 T op
mization work still has to be performed to increase GM/WM co
trast. However, diagnostic decision making was not hampered, as f
diagnostic evaluation the MP2RAGE sequence was primarily used. D
agnostic information such as the detection of intracellular and extrace
lular methemoglobin, which relies on a T1-weighted sequence, in o
experience was feasible using the T1 FLASH sequence at 7 T.
The well-known coil-related signal decrease in the posteri
fossa still poses a problem that is likely to be overcome with parall
transmit technology in the near future. Within our study, the perceptio
of pathologic imaging findings in the posterior fossa was not hampere
at 7 T, compared with the 3 Texamination—an accurate diagnosis of a
infratentorial metastasis was possible, where the image quality w
rated as 2 (moderate) by both readers.
A specific image feature has to be noted at 7 T: a hyperinten
rim which is visible on 7 T FLAIR images at the pial surface of the c
rebral cortex, which corresponds to the outer, glia-rich layers of the co
tex (layers I–III).39
Increased SNR through higher static magnetic field strength ca
be translated into higher spatial resolution or contrast or can be investe
into a reduction in scan time. To achieve a higher diagnostic confiden© 2016 Wolters Kluwer Health, Inc. All rights reserved.
                              Copyright © 2016 Wolters Kluwer Health, Inc. Unauthori
                              This paper can be cited using the date of access and thein clinical neuroimaging, the benefit of a higher spacial resolutio
within the same scan time should be used at ultra-high-field 7 T.
Adverse Effects
Thirteen subjects experienced mild dizziness during the exam
nation at 7 T, possibly related to the 7 T examination, the duration
the symptoms was less than 30 minutes in all cases. This is in acco
with previous studies as, for example, Dal-Bianco et al11 who reporte
a short episode of mild dizziness (of less than 2 minutes) for 2
10 patients when moved into the scanner.
Quantitative Analysis
SNR and CNR Evaluation
A requirement for protocol optimization was to obtain higher sp
tial resolution at 7 T in the same acquisition time and keep similar CN
at 7 T comparedwith 3 T, while obtaining an acceptable SNR.Within th
condition, imaging protocols were optimized by visual inspection (befo
this study) to yield the best visibility of anatomic structures (eg, GM
WM, veins) and pathologies. This process led to protocols with differe
resolutions, flip angles, echo times, receiver bandwidths, and acceleratio
factors at the 2 field strengths, making it challenging to distinguish the i
fluence of field strength on SNR and CNR from other factors. The mo
significant differing protocol factor was the higher spatial resolutio
in 8 of 11 sequences (Table 1). For that reason, we also presented SN
results that are scaled by the ratio of 3 T/7 T voxel sizes. In 10 of 1
sequences (all except T1 MP2RAGE 3D), the voxel-volume-normalize
SNR was higher at 7 T than at 3 T. This was true for health
volunteers and patient groups, and for phantom results, which we
assessed rigorously according to Dietrich et al.22 It should be note
that the voxel volume scaling does not remove SNR differenc
related to other parameters, so the generally higher voxel-volum
normalized SNR at 7 T cannot be attributed to field strength alon
Limitations of the Study
A limitation of this study is the limited number of patients
each of the 4 disease groups, although, in total, 40 patients underwe
an MR protocol of 10 sequences that required 1-hour scan time at eac
field strength. In addition, the imaging protocols used in this study we
optimized for clinical evaluation and not for quantitative SNR/CN
analysis. A rigorous comparison of the SNR at both field strengt
was not feasible, although phantom measurements made in accordan
with best practice22 suggest that our conclusions, if not the exact value
are well founded. The voxel volume correction we performed remov
the influence of different voxel sizes but does not allow remaining SN
differences to be attributed to the field strength alone: different RF coi
sequence parameters, relaxation times, and postprocessing options al
play a role. Identical resolution, receiver bandwidth, acceleration facto
flip angles, and many other parameters at both field strengths would b
desirable study modifications.
To the extent that this was possible, blinded reading was pe
formed for the semiquantitative analysis of the 3 pathology specif
criteria in each of the 4 disease groups. The field strength could be ide
tified in the majority of the sequences, primarily due to higher resol
tion, but also due to 7 T-specific image features such as, for exampl
the well-known hyperintense rim on 7 T FLAIR images at the pial co
tical surface corresponding to layer I to III of the cortex, and due to th
well-known coil-related signal decrease in the posterior fossa. Howeve
radiologists consciously aimed not to overrate 7 T MRI.
No contrast agent was administered to the patients, although th
would be desirable in the diagnostic workup of tumorous disease an
MS in daily clinical routine. A contrast administration to the patien
at both field strengths would not have been a reasonable burden
the patients, as the better contrast effect at 7 T compared to 3 T h
already been shown40 in tumorous disease. Moreover, we aimedwww.investigativeradiology.com 13
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              assess noncontrast imaging criteria that have the potential to gain clin
cal relevance and mainly through high-field MRI.
CONCLUSIONS
Ultra–high-field MRI at 7 T yielded an improved diagnost
confidence in the most frequently encountered neurologic disorder
compared with 3 T. A gain of precision was achieved for small stru
tures and subtle pathologies, for example, for CL detection in microva
cular disease andMS, or structural epileptogenic lesions in the tempor
lobe, as well as for depicting a central vein and iron accumulation
within an MS lesion. The major reason seems to be higher spatial an
contrast resolution achievable at 7 T. At ultra-high-field 7 T increase
SNR through higher static magnetic field strength should be translate
into higher spatial resolution and contrast within the same scan time
achieve a higher diagnostic confidence in clinical neuroimaging.
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